Announcement

Collapse
No announcement yet.

Topical timolol in dermatology: infantile hemangiomas and beyond

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Topical timolol in dermatology: infantile hemangiomas and beyond

    Timolol, a non-selective β-adrenergic receptor blocker, is well-tolerated and is becoming increasingly popular in dermatology especially after its use in the management of infantile hemangiomas. Its effects are mainly due to vasoconstriction, inhibition of angiogenesis and keratinocyte migration promotion for re-epithelialization and wound healing. We review the evidence behind the use of timolol in several dermatological conditions including infantile hemangiomas, pyogenic granulomas, Kaposi's...

    More...
Working...
X